AROMATASE INHIBITOR- INDUCED CHANGES IN THE LIPID PROFILE OF POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER.

被引:0
|
作者
Bell, L. N. [1 ]
Nguyen, A. T. [1 ]
Li, L. [1 ]
Desta, Z. [1 ]
Flockhart, D. A. [1 ]
机构
[1] Indiana Univ, Indianapolis, IN 46204 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S79 / S79
页数:1
相关论文
共 50 条
  • [42] Effect of combination therapy of eldecalcitol and risedronate on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: an open-label randomized trial
    Imanishi, Yasuo
    Imai, Takumi
    Fujii, Hisako
    Aida, Rei
    Nagata, Yuki
    Shoji, Tetsuo
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Emoto, Masanori
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 358 - 359
  • [43] Pharmacokinetic and pharmacodynamic interaction of adjuvant tamoxifen and exemestane in postmenopausal women treated for early stage breast cancer.
    Hutson, PR
    Love, RR
    Cleary, JF
    Kim, K
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S74 - S74
  • [44] Periodontal health in early-stage postmenopausal breast cancer survivors on aromatase inhibitors
    Taichman, L. Susan
    Inglehart, Marita
    Giannobile, William
    Braun, Thomas
    Kolenic, Giselle
    Van Poznak, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis
    Anagha, Pooleriveetil Padikkal
    Sen, Suchandra
    JOURNAL OF ONCOLOGY, 2014, 2014
  • [46] Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy
    Pedersini, Rebecca
    di Mauro, Pierluigi
    Amoroso, Vito
    Castronovo, Vincenza
    Zamparini, Manuel
    Monteverdi, Sara
    Laini, Lara
    Schivardi, Greta
    Cosentini, Deborah
    Grisanti, Salvatore
    Marelli, Sara
    Strambi, Luigi Ferini
    Berruti, Alfredo
    BREAST, 2022, 66 : 162 - 168
  • [47] Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
    Dent, Susan F.
    Gaspo, Rania
    Kissner, Michelle
    Pritchard, Kathleen I.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (02) : 295 - 310
  • [48] Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
    Susan F. Dent
    Rania Gaspo
    Michelle Kissner
    Kathleen I. Pritchard
    Breast Cancer Research and Treatment, 2011, 126 : 295 - 310
  • [49] Association of variants in candidate genes on lipid profiles in women with early breast cancer on adjuvant aromatase inhibitor therapy
    Santa-Maria, C. A.
    Dantzer, J.
    Li, L.
    Skaar, T.
    Oesterreich, S.
    Rae, J. M.
    Zeruesenay, D.
    Nguyen, A. T.
    Henry, N. L.
    Storniolo, A. M.
    Hayes, D. F.
    Blumenthal, R. S.
    Ouyang, P.
    Post, W.
    Flockhart, D. A.
    Stearns, V.
    CANCER RESEARCH, 2013, 73
  • [50] Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
    Santa-Maria, Cesar A.
    Blackford, Amanda
    Nguyen, Anne T.
    Skaar, Todd C.
    Philips, Santosh
    Oesterreich, Steffi
    Rae, James M.
    Desta, Zeruesenay
    Robarge, Jason
    Henry, Norah Lynn
    Storniolo, Anna M.
    Hayes, Daniel F.
    Blumenthal, Roger S.
    Ouyang, Pamela
    Post, Wendy S.
    Flockhart, David A.
    Stearns, Vered
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1395 - 1402